nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—Cisplatin—testicular cancer	0.102	0.157	CbGbCtD
Etoricoxib—PTGS2—Etoposide—testicular cancer	0.0998	0.154	CbGbCtD
Etoricoxib—CYP2C19—Ifosfamide—testicular cancer	0.0854	0.132	CbGbCtD
Etoricoxib—CYP2C9—Ifosfamide—testicular cancer	0.071	0.11	CbGbCtD
Etoricoxib—CYP2E1—Etoposide—testicular cancer	0.0651	0.101	CbGbCtD
Etoricoxib—CYP3A4—Ifosfamide—testicular cancer	0.0413	0.0638	CbGbCtD
Etoricoxib—CYP1A2—Etoposide—testicular cancer	0.0376	0.0582	CbGbCtD
Etoricoxib—CYP2C9—Cisplatin—testicular cancer	0.0345	0.0534	CbGbCtD
Etoricoxib—CYP2D6—Vinblastine—testicular cancer	0.0344	0.0532	CbGbCtD
Etoricoxib—CYP3A4—Vinblastine—testicular cancer	0.0219	0.0338	CbGbCtD
Etoricoxib—CYP2D6—Doxorubicin—testicular cancer	0.0212	0.0327	CbGbCtD
Etoricoxib—CYP3A4—Etoposide—testicular cancer	0.0197	0.0305	CbGbCtD
Etoricoxib—CYP3A4—Doxorubicin—testicular cancer	0.0135	0.0208	CbGbCtD
Etoricoxib—Stomatitis—Epirubicin—testicular cancer	0.000252	0.000714	CcSEcCtD
Etoricoxib—Jaundice—Epirubicin—testicular cancer	0.000252	0.000714	CcSEcCtD
Etoricoxib—Pain—Etoposide—testicular cancer	0.000251	0.000712	CcSEcCtD
Etoricoxib—Constipation—Etoposide—testicular cancer	0.000251	0.000712	CcSEcCtD
Etoricoxib—Urinary tract infection—Epirubicin—testicular cancer	0.000251	0.000712	CcSEcCtD
Etoricoxib—Conjunctivitis—Epirubicin—testicular cancer	0.000251	0.000712	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000249	0.000706	CcSEcCtD
Etoricoxib—Haemoglobin—Methotrexate—testicular cancer	0.000249	0.000706	CcSEcCtD
Etoricoxib—Haemorrhage—Methotrexate—testicular cancer	0.000248	0.000702	CcSEcCtD
Etoricoxib—Hepatitis—Methotrexate—testicular cancer	0.000248	0.000702	CcSEcCtD
Etoricoxib—Haematuria—Epirubicin—testicular cancer	0.000246	0.000698	CcSEcCtD
Etoricoxib—Dizziness—Ifosfamide—testicular cancer	0.000246	0.000697	CcSEcCtD
Etoricoxib—Pharyngitis—Methotrexate—testicular cancer	0.000246	0.000697	CcSEcCtD
Etoricoxib—Urinary tract disorder—Methotrexate—testicular cancer	0.000245	0.000694	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000245	0.000693	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Epirubicin—testicular cancer	0.000244	0.000692	CcSEcCtD
Etoricoxib—Weight increased—Doxorubicin—testicular cancer	0.000244	0.000691	CcSEcCtD
Etoricoxib—Epistaxis—Epirubicin—testicular cancer	0.000244	0.000691	CcSEcCtD
Etoricoxib—Urethral disorder—Methotrexate—testicular cancer	0.000243	0.000688	CcSEcCtD
Etoricoxib—Sinusitis—Epirubicin—testicular cancer	0.000242	0.000687	CcSEcCtD
Etoricoxib—Feeling abnormal—Etoposide—testicular cancer	0.000242	0.000686	CcSEcCtD
Etoricoxib—Hyperglycaemia—Doxorubicin—testicular cancer	0.000242	0.000685	CcSEcCtD
Etoricoxib—Nausea—Dactinomycin—testicular cancer	0.000241	0.000684	CcSEcCtD
Etoricoxib—Pneumonia—Doxorubicin—testicular cancer	0.000241	0.000681	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Etoposide—testicular cancer	0.00024	0.000681	CcSEcCtD
Etoricoxib—Infestation NOS—Doxorubicin—testicular cancer	0.000239	0.000677	CcSEcCtD
Etoricoxib—Infestation—Doxorubicin—testicular cancer	0.000239	0.000677	CcSEcCtD
Etoricoxib—Visual impairment—Methotrexate—testicular cancer	0.000239	0.000677	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000237	0.000672	CcSEcCtD
Etoricoxib—Vomiting—Ifosfamide—testicular cancer	0.000237	0.000671	CcSEcCtD
Etoricoxib—Hypersensitivity—Cisplatin—testicular cancer	0.000237	0.00067	CcSEcCtD
Etoricoxib—Renal failure—Doxorubicin—testicular cancer	0.000235	0.000666	CcSEcCtD
Etoricoxib—Rash—Ifosfamide—testicular cancer	0.000235	0.000665	CcSEcCtD
Etoricoxib—Dermatitis—Ifosfamide—testicular cancer	0.000235	0.000664	CcSEcCtD
Etoricoxib—Erythema multiforme—Methotrexate—testicular cancer	0.000234	0.000664	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000234	0.000664	CcSEcCtD
Etoricoxib—Urticaria—Etoposide—testicular cancer	0.000234	0.000662	CcSEcCtD
Etoricoxib—Haemoglobin—Epirubicin—testicular cancer	0.000233	0.000661	CcSEcCtD
Etoricoxib—Stomatitis—Doxorubicin—testicular cancer	0.000233	0.00066	CcSEcCtD
Etoricoxib—Jaundice—Doxorubicin—testicular cancer	0.000233	0.00066	CcSEcCtD
Etoricoxib—Abdominal pain—Etoposide—testicular cancer	0.000232	0.000658	CcSEcCtD
Etoricoxib—Urinary tract infection—Doxorubicin—testicular cancer	0.000232	0.000658	CcSEcCtD
Etoricoxib—Conjunctivitis—Doxorubicin—testicular cancer	0.000232	0.000658	CcSEcCtD
Etoricoxib—Haemorrhage—Epirubicin—testicular cancer	0.000232	0.000657	CcSEcCtD
Etoricoxib—Hepatitis—Epirubicin—testicular cancer	0.000232	0.000657	CcSEcCtD
Etoricoxib—Eye disorder—Methotrexate—testicular cancer	0.000232	0.000656	CcSEcCtD
Etoricoxib—Tinnitus—Methotrexate—testicular cancer	0.000231	0.000655	CcSEcCtD
Etoricoxib—Hypoaesthesia—Epirubicin—testicular cancer	0.000231	0.000654	CcSEcCtD
Etoricoxib—Asthenia—Cisplatin—testicular cancer	0.00023	0.000652	CcSEcCtD
Etoricoxib—Pharyngitis—Epirubicin—testicular cancer	0.00023	0.000652	CcSEcCtD
Etoricoxib—Cardiac disorder—Methotrexate—testicular cancer	0.00023	0.000652	CcSEcCtD
Etoricoxib—Urinary tract disorder—Epirubicin—testicular cancer	0.000229	0.000649	CcSEcCtD
Etoricoxib—Oedema peripheral—Epirubicin—testicular cancer	0.000229	0.000647	CcSEcCtD
Etoricoxib—Haematuria—Doxorubicin—testicular cancer	0.000228	0.000646	CcSEcCtD
Etoricoxib—Connective tissue disorder—Epirubicin—testicular cancer	0.000228	0.000646	CcSEcCtD
Etoricoxib—Urethral disorder—Epirubicin—testicular cancer	0.000227	0.000644	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000226	0.000641	CcSEcCtD
Etoricoxib—Epistaxis—Doxorubicin—testicular cancer	0.000226	0.000639	CcSEcCtD
Etoricoxib—Angiopathy—Methotrexate—testicular cancer	0.000225	0.000637	CcSEcCtD
Etoricoxib—Sinusitis—Doxorubicin—testicular cancer	0.000224	0.000636	CcSEcCtD
Etoricoxib—Immune system disorder—Methotrexate—testicular cancer	0.000224	0.000634	CcSEcCtD
Etoricoxib—Visual impairment—Epirubicin—testicular cancer	0.000224	0.000633	CcSEcCtD
Etoricoxib—Mediastinal disorder—Methotrexate—testicular cancer	0.000223	0.000633	CcSEcCtD
Etoricoxib—Nausea—Ifosfamide—testicular cancer	0.000221	0.000626	CcSEcCtD
Etoricoxib—Diarrhoea—Cisplatin—testicular cancer	0.00022	0.000622	CcSEcCtD
Etoricoxib—Erythema multiforme—Epirubicin—testicular cancer	0.000219	0.000621	CcSEcCtD
Etoricoxib—Alopecia—Methotrexate—testicular cancer	0.000219	0.000621	CcSEcCtD
Etoricoxib—Mental disorder—Methotrexate—testicular cancer	0.000217	0.000615	CcSEcCtD
Etoricoxib—Eye disorder—Epirubicin—testicular cancer	0.000217	0.000614	CcSEcCtD
Etoricoxib—Hypersensitivity—Etoposide—testicular cancer	0.000217	0.000614	CcSEcCtD
Etoricoxib—Tinnitus—Epirubicin—testicular cancer	0.000216	0.000613	CcSEcCtD
Etoricoxib—Erythema—Methotrexate—testicular cancer	0.000216	0.000611	CcSEcCtD
Etoricoxib—Malnutrition—Methotrexate—testicular cancer	0.000216	0.000611	CcSEcCtD
Etoricoxib—Haemoglobin—Doxorubicin—testicular cancer	0.000216	0.000611	CcSEcCtD
Etoricoxib—Flushing—Epirubicin—testicular cancer	0.000215	0.00061	CcSEcCtD
Etoricoxib—Cardiac disorder—Epirubicin—testicular cancer	0.000215	0.00061	CcSEcCtD
Etoricoxib—Haemorrhage—Doxorubicin—testicular cancer	0.000215	0.000608	CcSEcCtD
Etoricoxib—Hepatitis—Doxorubicin—testicular cancer	0.000215	0.000608	CcSEcCtD
Etoricoxib—Hypoaesthesia—Doxorubicin—testicular cancer	0.000214	0.000605	CcSEcCtD
Etoricoxib—Pharyngitis—Doxorubicin—testicular cancer	0.000213	0.000604	CcSEcCtD
Etoricoxib—Urinary tract disorder—Doxorubicin—testicular cancer	0.000212	0.000601	CcSEcCtD
Etoricoxib—Oedema peripheral—Doxorubicin—testicular cancer	0.000211	0.000599	CcSEcCtD
Etoricoxib—Dysgeusia—Methotrexate—testicular cancer	0.000211	0.000599	CcSEcCtD
Etoricoxib—Asthenia—Etoposide—testicular cancer	0.000211	0.000598	CcSEcCtD
Etoricoxib—Connective tissue disorder—Doxorubicin—testicular cancer	0.000211	0.000598	CcSEcCtD
Etoricoxib—Angiopathy—Epirubicin—testicular cancer	0.000211	0.000596	CcSEcCtD
Etoricoxib—Urethral disorder—Doxorubicin—testicular cancer	0.00021	0.000596	CcSEcCtD
Etoricoxib—Immune system disorder—Epirubicin—testicular cancer	0.00021	0.000594	CcSEcCtD
Etoricoxib—Mediastinal disorder—Epirubicin—testicular cancer	0.000209	0.000592	CcSEcCtD
Etoricoxib—Pruritus—Etoposide—testicular cancer	0.000208	0.000589	CcSEcCtD
Etoricoxib—Arrhythmia—Epirubicin—testicular cancer	0.000207	0.000587	CcSEcCtD
Etoricoxib—Visual impairment—Doxorubicin—testicular cancer	0.000207	0.000586	CcSEcCtD
Etoricoxib—Alopecia—Epirubicin—testicular cancer	0.000205	0.000581	CcSEcCtD
Etoricoxib—Vomiting—Cisplatin—testicular cancer	0.000204	0.000578	CcSEcCtD
Etoricoxib—Vision blurred—Methotrexate—testicular cancer	0.000203	0.000576	CcSEcCtD
Etoricoxib—Mental disorder—Epirubicin—testicular cancer	0.000203	0.000576	CcSEcCtD
Etoricoxib—Erythema multiforme—Doxorubicin—testicular cancer	0.000203	0.000575	CcSEcCtD
Etoricoxib—Rash—Cisplatin—testicular cancer	0.000202	0.000573	CcSEcCtD
Etoricoxib—Dermatitis—Cisplatin—testicular cancer	0.000202	0.000573	CcSEcCtD
Etoricoxib—Erythema—Epirubicin—testicular cancer	0.000202	0.000572	CcSEcCtD
Etoricoxib—Malnutrition—Epirubicin—testicular cancer	0.000202	0.000572	CcSEcCtD
Etoricoxib—Diarrhoea—Etoposide—testicular cancer	0.000201	0.00057	CcSEcCtD
Etoricoxib—Eye disorder—Doxorubicin—testicular cancer	0.000201	0.000568	CcSEcCtD
Etoricoxib—Tinnitus—Doxorubicin—testicular cancer	0.0002	0.000567	CcSEcCtD
Etoricoxib—Anaemia—Methotrexate—testicular cancer	0.000199	0.000565	CcSEcCtD
Etoricoxib—Flushing—Doxorubicin—testicular cancer	0.000199	0.000564	CcSEcCtD
Etoricoxib—Cardiac disorder—Doxorubicin—testicular cancer	0.000199	0.000564	CcSEcCtD
Etoricoxib—Flatulence—Epirubicin—testicular cancer	0.000199	0.000564	CcSEcCtD
Etoricoxib—Dysgeusia—Epirubicin—testicular cancer	0.000198	0.00056	CcSEcCtD
Etoricoxib—Angiopathy—Doxorubicin—testicular cancer	0.000195	0.000552	CcSEcCtD
Etoricoxib—Dizziness—Etoposide—testicular cancer	0.000194	0.000551	CcSEcCtD
Etoricoxib—Muscle spasms—Epirubicin—testicular cancer	0.000194	0.00055	CcSEcCtD
Etoricoxib—Immune system disorder—Doxorubicin—testicular cancer	0.000194	0.000549	CcSEcCtD
Etoricoxib—Mediastinal disorder—Doxorubicin—testicular cancer	0.000193	0.000548	CcSEcCtD
Etoricoxib—Arrhythmia—Doxorubicin—testicular cancer	0.000192	0.000543	CcSEcCtD
Etoricoxib—Nausea—Cisplatin—testicular cancer	0.000191	0.00054	CcSEcCtD
Etoricoxib—Vision blurred—Epirubicin—testicular cancer	0.00019	0.000539	CcSEcCtD
Etoricoxib—Alopecia—Doxorubicin—testicular cancer	0.00019	0.000537	CcSEcCtD
Etoricoxib—Cough—Methotrexate—testicular cancer	0.000188	0.000533	CcSEcCtD
Etoricoxib—Mental disorder—Doxorubicin—testicular cancer	0.000188	0.000533	CcSEcCtD
Etoricoxib—Vomiting—Etoposide—testicular cancer	0.000187	0.00053	CcSEcCtD
Etoricoxib—Malnutrition—Doxorubicin—testicular cancer	0.000187	0.000529	CcSEcCtD
Etoricoxib—Erythema—Doxorubicin—testicular cancer	0.000187	0.000529	CcSEcCtD
Etoricoxib—Anaemia—Epirubicin—testicular cancer	0.000187	0.000529	CcSEcCtD
Etoricoxib—Agitation—Epirubicin—testicular cancer	0.000186	0.000526	CcSEcCtD
Etoricoxib—Rash—Etoposide—testicular cancer	0.000185	0.000525	CcSEcCtD
Etoricoxib—Dermatitis—Etoposide—testicular cancer	0.000185	0.000525	CcSEcCtD
Etoricoxib—Headache—Etoposide—testicular cancer	0.000184	0.000522	CcSEcCtD
Etoricoxib—Flatulence—Doxorubicin—testicular cancer	0.000184	0.000522	CcSEcCtD
Etoricoxib—Arthralgia—Methotrexate—testicular cancer	0.000184	0.00052	CcSEcCtD
Etoricoxib—Chest pain—Methotrexate—testicular cancer	0.000184	0.00052	CcSEcCtD
Etoricoxib—Dysgeusia—Doxorubicin—testicular cancer	0.000183	0.000518	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000182	0.000517	CcSEcCtD
Etoricoxib—Muscle spasms—Doxorubicin—testicular cancer	0.00018	0.000509	CcSEcCtD
Etoricoxib—Palpitations—Epirubicin—testicular cancer	0.000178	0.000506	CcSEcCtD
Etoricoxib—Confusional state—Methotrexate—testicular cancer	0.000178	0.000503	CcSEcCtD
Etoricoxib—Cough—Epirubicin—testicular cancer	0.000176	0.000499	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methotrexate—testicular cancer	0.000176	0.000499	CcSEcCtD
Etoricoxib—Vision blurred—Doxorubicin—testicular cancer	0.000176	0.000499	CcSEcCtD
Etoricoxib—Infection—Methotrexate—testicular cancer	0.000175	0.000496	CcSEcCtD
Etoricoxib—Nausea—Etoposide—testicular cancer	0.000175	0.000495	CcSEcCtD
Etoricoxib—Hypertension—Epirubicin—testicular cancer	0.000174	0.000494	CcSEcCtD
Etoricoxib—Nervous system disorder—Methotrexate—testicular cancer	0.000173	0.000489	CcSEcCtD
Etoricoxib—Anaemia—Doxorubicin—testicular cancer	0.000173	0.000489	CcSEcCtD
Etoricoxib—Thrombocytopenia—Methotrexate—testicular cancer	0.000172	0.000489	CcSEcCtD
Etoricoxib—Arthralgia—Epirubicin—testicular cancer	0.000172	0.000487	CcSEcCtD
Etoricoxib—Chest pain—Epirubicin—testicular cancer	0.000172	0.000487	CcSEcCtD
Etoricoxib—Agitation—Doxorubicin—testicular cancer	0.000172	0.000486	CcSEcCtD
Etoricoxib—Anxiety—Epirubicin—testicular cancer	0.000171	0.000485	CcSEcCtD
Etoricoxib—Skin disorder—Methotrexate—testicular cancer	0.000171	0.000485	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000171	0.000484	CcSEcCtD
Etoricoxib—Dry mouth—Epirubicin—testicular cancer	0.000168	0.000476	CcSEcCtD
Etoricoxib—Anorexia—Methotrexate—testicular cancer	0.000168	0.000476	CcSEcCtD
Etoricoxib—Confusional state—Epirubicin—testicular cancer	0.000166	0.000471	CcSEcCtD
Etoricoxib—Palpitations—Doxorubicin—testicular cancer	0.000165	0.000468	CcSEcCtD
Etoricoxib—Anaphylactic shock—Epirubicin—testicular cancer	0.000165	0.000467	CcSEcCtD
Etoricoxib—Oedema—Epirubicin—testicular cancer	0.000165	0.000467	CcSEcCtD
Etoricoxib—Infection—Epirubicin—testicular cancer	0.000164	0.000464	CcSEcCtD
Etoricoxib—Cough—Doxorubicin—testicular cancer	0.000163	0.000462	CcSEcCtD
Etoricoxib—Shock—Epirubicin—testicular cancer	0.000162	0.000459	CcSEcCtD
Etoricoxib—Nervous system disorder—Epirubicin—testicular cancer	0.000162	0.000458	CcSEcCtD
Etoricoxib—Thrombocytopenia—Epirubicin—testicular cancer	0.000161	0.000457	CcSEcCtD
Etoricoxib—Hypertension—Doxorubicin—testicular cancer	0.000161	0.000457	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00016	0.000455	CcSEcCtD
Etoricoxib—Skin disorder—Epirubicin—testicular cancer	0.00016	0.000454	CcSEcCtD
Etoricoxib—Insomnia—Methotrexate—testicular cancer	0.000159	0.000451	CcSEcCtD
Etoricoxib—Arthralgia—Doxorubicin—testicular cancer	0.000159	0.000451	CcSEcCtD
Etoricoxib—Chest pain—Doxorubicin—testicular cancer	0.000159	0.000451	CcSEcCtD
Etoricoxib—Anxiety—Doxorubicin—testicular cancer	0.000159	0.000449	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000158	0.000448	CcSEcCtD
Etoricoxib—Anorexia—Epirubicin—testicular cancer	0.000157	0.000445	CcSEcCtD
Etoricoxib—Dyspnoea—Methotrexate—testicular cancer	0.000157	0.000445	CcSEcCtD
Etoricoxib—Somnolence—Methotrexate—testicular cancer	0.000157	0.000444	CcSEcCtD
Etoricoxib—Dry mouth—Doxorubicin—testicular cancer	0.000156	0.000441	CcSEcCtD
Etoricoxib—Dyspepsia—Methotrexate—testicular cancer	0.000155	0.000439	CcSEcCtD
Etoricoxib—Confusional state—Doxorubicin—testicular cancer	0.000154	0.000436	CcSEcCtD
Etoricoxib—Decreased appetite—Methotrexate—testicular cancer	0.000153	0.000434	CcSEcCtD
Etoricoxib—Oedema—Doxorubicin—testicular cancer	0.000153	0.000432	CcSEcCtD
Etoricoxib—Anaphylactic shock—Doxorubicin—testicular cancer	0.000153	0.000432	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000152	0.000431	CcSEcCtD
Etoricoxib—Fatigue—Methotrexate—testicular cancer	0.000152	0.00043	CcSEcCtD
Etoricoxib—Infection—Doxorubicin—testicular cancer	0.000152	0.000429	CcSEcCtD
Etoricoxib—Pain—Methotrexate—testicular cancer	0.000151	0.000427	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.00015	0.000425	CcSEcCtD
Etoricoxib—Shock—Doxorubicin—testicular cancer	0.00015	0.000425	CcSEcCtD
Etoricoxib—Nervous system disorder—Doxorubicin—testicular cancer	0.00015	0.000424	CcSEcCtD
Etoricoxib—Thrombocytopenia—Doxorubicin—testicular cancer	0.000149	0.000423	CcSEcCtD
Etoricoxib—Insomnia—Epirubicin—testicular cancer	0.000149	0.000422	CcSEcCtD
Etoricoxib—Skin disorder—Doxorubicin—testicular cancer	0.000148	0.00042	CcSEcCtD
Etoricoxib—Dyspnoea—Epirubicin—testicular cancer	0.000147	0.000416	CcSEcCtD
Etoricoxib—Somnolence—Epirubicin—testicular cancer	0.000147	0.000415	CcSEcCtD
Etoricoxib—Anorexia—Doxorubicin—testicular cancer	0.000145	0.000412	CcSEcCtD
Etoricoxib—Feeling abnormal—Methotrexate—testicular cancer	0.000145	0.000411	CcSEcCtD
Etoricoxib—Dyspepsia—Epirubicin—testicular cancer	0.000145	0.000411	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methotrexate—testicular cancer	0.000144	0.000408	CcSEcCtD
Etoricoxib—Decreased appetite—Epirubicin—testicular cancer	0.000143	0.000406	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000142	0.000403	CcSEcCtD
Etoricoxib—Fatigue—Epirubicin—testicular cancer	0.000142	0.000403	CcSEcCtD
Etoricoxib—Constipation—Epirubicin—testicular cancer	0.000141	0.000399	CcSEcCtD
Etoricoxib—Pain—Epirubicin—testicular cancer	0.000141	0.000399	CcSEcCtD
Etoricoxib—Urticaria—Methotrexate—testicular cancer	0.00014	0.000396	CcSEcCtD
Etoricoxib—Abdominal pain—Methotrexate—testicular cancer	0.000139	0.000394	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000139	0.000394	CcSEcCtD
Etoricoxib—Insomnia—Doxorubicin—testicular cancer	0.000138	0.000391	CcSEcCtD
Etoricoxib—Dyspnoea—Doxorubicin—testicular cancer	0.000136	0.000385	CcSEcCtD
Etoricoxib—Feeling abnormal—Epirubicin—testicular cancer	0.000136	0.000385	CcSEcCtD
Etoricoxib—Somnolence—Doxorubicin—testicular cancer	0.000136	0.000384	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Epirubicin—testicular cancer	0.000135	0.000382	CcSEcCtD
Etoricoxib—Dyspepsia—Doxorubicin—testicular cancer	0.000134	0.00038	CcSEcCtD
Etoricoxib—Decreased appetite—Doxorubicin—testicular cancer	0.000133	0.000376	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000132	0.000373	CcSEcCtD
Etoricoxib—Fatigue—Doxorubicin—testicular cancer	0.000132	0.000372	CcSEcCtD
Etoricoxib—Urticaria—Epirubicin—testicular cancer	0.000131	0.000371	CcSEcCtD
Etoricoxib—Constipation—Doxorubicin—testicular cancer	0.00013	0.000369	CcSEcCtD
Etoricoxib—Pain—Doxorubicin—testicular cancer	0.00013	0.000369	CcSEcCtD
Etoricoxib—Abdominal pain—Epirubicin—testicular cancer	0.00013	0.000369	CcSEcCtD
Etoricoxib—Hypersensitivity—Methotrexate—testicular cancer	0.00013	0.000368	CcSEcCtD
Etoricoxib—Asthenia—Methotrexate—testicular cancer	0.000126	0.000358	CcSEcCtD
Etoricoxib—Feeling abnormal—Doxorubicin—testicular cancer	0.000126	0.000356	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000125	0.000353	CcSEcCtD
Etoricoxib—Pruritus—Methotrexate—testicular cancer	0.000125	0.000353	CcSEcCtD
Etoricoxib—Hypersensitivity—Epirubicin—testicular cancer	0.000121	0.000344	CcSEcCtD
Etoricoxib—Urticaria—Doxorubicin—testicular cancer	0.000121	0.000343	CcSEcCtD
Etoricoxib—Abdominal pain—Doxorubicin—testicular cancer	0.000121	0.000342	CcSEcCtD
Etoricoxib—Diarrhoea—Methotrexate—testicular cancer	0.000121	0.000341	CcSEcCtD
Etoricoxib—Asthenia—Epirubicin—testicular cancer	0.000118	0.000335	CcSEcCtD
Etoricoxib—Pruritus—Epirubicin—testicular cancer	0.000117	0.00033	CcSEcCtD
Etoricoxib—Dizziness—Methotrexate—testicular cancer	0.000116	0.00033	CcSEcCtD
Etoricoxib—Diarrhoea—Epirubicin—testicular cancer	0.000113	0.000319	CcSEcCtD
Etoricoxib—Hypersensitivity—Doxorubicin—testicular cancer	0.000112	0.000318	CcSEcCtD
Etoricoxib—Vomiting—Methotrexate—testicular cancer	0.000112	0.000317	CcSEcCtD
Etoricoxib—Rash—Methotrexate—testicular cancer	0.000111	0.000315	CcSEcCtD
Etoricoxib—Dermatitis—Methotrexate—testicular cancer	0.000111	0.000314	CcSEcCtD
Etoricoxib—Headache—Methotrexate—testicular cancer	0.00011	0.000313	CcSEcCtD
Etoricoxib—Asthenia—Doxorubicin—testicular cancer	0.000109	0.00031	CcSEcCtD
Etoricoxib—Dizziness—Epirubicin—testicular cancer	0.000109	0.000309	CcSEcCtD
Etoricoxib—Pruritus—Doxorubicin—testicular cancer	0.000108	0.000306	CcSEcCtD
Etoricoxib—Vomiting—Epirubicin—testicular cancer	0.000105	0.000297	CcSEcCtD
Etoricoxib—Nausea—Methotrexate—testicular cancer	0.000105	0.000296	CcSEcCtD
Etoricoxib—Diarrhoea—Doxorubicin—testicular cancer	0.000104	0.000296	CcSEcCtD
Etoricoxib—Rash—Epirubicin—testicular cancer	0.000104	0.000294	CcSEcCtD
Etoricoxib—Dermatitis—Epirubicin—testicular cancer	0.000104	0.000294	CcSEcCtD
Etoricoxib—Headache—Epirubicin—testicular cancer	0.000103	0.000293	CcSEcCtD
Etoricoxib—Dizziness—Doxorubicin—testicular cancer	0.000101	0.000286	CcSEcCtD
Etoricoxib—Nausea—Epirubicin—testicular cancer	9.79e-05	0.000277	CcSEcCtD
Etoricoxib—Vomiting—Doxorubicin—testicular cancer	9.7e-05	0.000275	CcSEcCtD
Etoricoxib—Rash—Doxorubicin—testicular cancer	9.62e-05	0.000272	CcSEcCtD
Etoricoxib—Dermatitis—Doxorubicin—testicular cancer	9.61e-05	0.000272	CcSEcCtD
Etoricoxib—Headache—Doxorubicin—testicular cancer	9.56e-05	0.000271	CcSEcCtD
Etoricoxib—Nausea—Doxorubicin—testicular cancer	9.06e-05	0.000257	CcSEcCtD
